Published in J Am Coll Cardiol on January 01, 2000
Determinants of persistent negative T waves and early versus late T wave normalisation after acute myocardial infarction. Heart (2005) 0.85
Relation between early mitral regurgitation and left ventricular thrombus formation after acute myocardial infarction: results of the GISSI-3 echo substudy. Heart (2002) 0.81
Diagnosis and treatment of asymptomatic left ventricular systolic dysfunction after myocardial infarction. ISRN Cardiol (2013) 0.75
Application of adenosine stress echocardiography in the prognosis of acute myocardial infarction following percutaneous coronary interventional therapy. Exp Ther Med (2013) 0.75
Cardioprotective effects of transthoracic microelectrostimulation. Dokl Biol Sci (2002) 0.75
Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol (2001) 4.07
Physiology and pathophysiology of heart rate and blood pressure variability in humans: is power spectral analysis largely an index of baroreflex gain? Clin Sci (Lond) (1995) 2.92
Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71
Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation (1999) 2.55
A comparison of the early outcome of acute myocardial infarction in women and men. The Third International Study of Infarct Survival Collaborative Group. N Engl J Med (1998) 2.42
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation (2000) 2.19
Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J (2001) 2.07
[Cardiologists and limitations of statins reimbursement]. Ital Heart J Suppl (2000) 2.03
Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications. Circulation (1997) 2.03
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
[Debate on chronic cardiopathy]. G Ital Cardiol (1992) 2.01
Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation (1997) 1.97
Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy. Am J Cardiol (2000) 1.86
Relationship between HbA1c levels and risk of cardiovascular adverse outcomes and all-cause mortality in overweight and obese cardiovascular high-risk women and men with type 2 diabetes. Diabetologia (2012) 1.85
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
Recommendations for transoesophageal echocardiography: update 2010. Eur J Echocardiogr (2010) 1.75
ACE inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation (1995) 1.75
Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation (1993) 1.74
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety. Europace (2007) 1.73
Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol (1999) 1.71
Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy. Eur Heart J (2000) 1.68
Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction: data from the GISSI-3 study. Circulation (1997) 1.68
Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area. Circulation (1994) 1.68
Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J (2001) 1.66
Relationship between psychological profile and cardiological variables in chronic heart failure. The role of patient subjectivity. Eur Heart J (1999) 1.65
[Adherence to guidelines in CHF therapy in Germany]. Dtsch Med Wochenschr (2005) 1.58
Epidemiology of post-infarction risk stratification strategies in a country with a low volume of revascularization procedures. GISSI-Prognosis Investigators. Eur Heart J (1998) 1.56
Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J (1996) 1.56
Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J (2001) 1.53
Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation (1997) 1.49
The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. Eur J Heart Fail (2001) 1.49
Thromboembolic risk in atrial flutter. The FLASIEC (FLutter Atriale Società Italiana di Ecografia Cardiovascolare) multicentre study. Eur Heart J (2001) 1.48
Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Application of a new dilatation model to GISSI-3 data. Eur Heart J (2002) 1.48
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol (2001) 1.47
[Right ventricular thrombosis in arrhythmogenic cardiomyopathy. A case report]. Ital Heart J Suppl (2000) 1.46
Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. Heart Dis (2001) 1.45
Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol (1996) 1.45
Demonstration of the relationship between heart dimensions and QRS voltage amplitude. J Electrocardiol (1996) 1.42
Concomitant factors of decompensation in chronic heart failure. Am J Cardiol (1996) 1.42
Thromboembolic complications after electrical cardioversion in patients with atrial flutter. Am J Med (2001) 1.41
The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
[GISSI and "informed consent"]. G Ital Cardiol (1992) 1.40
[The history of the SET-UP study (or how difficult is neutrality in clinical research)]. Ital Heart J Suppl (2000) 1.40
Evidence-based therapeutic strategies. There is the need to bridge the gap between simplified megatrials and individual prescriptions. Ital Heart J (2001) 1.40
[Severe mitral insufficiency: the current surgical indications and new prospects]. G Ital Cardiol (1994) 1.39
[The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type]. Ital Heart J Suppl (2000) 1.39
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. Catheter Cardiovasc Interv (2005) 1.39
Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. N Engl J Med (1977) 1.38
Early right coronary vasospasm presenting with malignant arrhythmias in a heart transplantation recipient without allograft vasculopathy. Int J Cardiol (2007) 1.38
Low energy intracardiac cardioversion of chronic atrial fibrillation by single femoral approach: safety and effectiveness of the procedure. Ital Heart J (2000) 1.38
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial. Am Heart J (1999) 1.36
A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health (1994) 1.35
Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol (1993) 1.34
Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data. Heart (2001) 1.32
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet (1994) 1.32
Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids (2001) 1.27
Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation (1996) 1.22
Even-numbered rhombomeres control the apoptotic elimination of neural crest cells from odd-numbered rhombomeres in the chick hindbrain. Development (1993) 1.21
Doppler-derived mitral deceleration time of early filling as a strong predictor of pulmonary capillary wedge pressure in postinfarction patients with left ventricular systolic dysfunction. J Am Coll Cardiol (1994) 1.19
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. Diabetes Obes Metab (2012) 1.19
The "macromolecular tourist": universal temperature dependence of thermal diffusion in aqueous colloidal suspensions. Eur Phys J E Soft Matter (2006) 1.17
Heart failure-related myopathy. Clinical and pathophysiological insights. Eur Heart J (1999) 1.17
Heterogeneity of left ventricular remodeling after acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-3 Echo Substudy. Am Heart J (2001) 1.17